Rafarma Pharmaceuticals, Inc. (RAFA) Enters Production Agreement to Manufacture Pharmaceutical Product
Rafarma Pharmaceuticals announced that it entered into a production agreement last month to manufacture Para-Aminosalicylic Acid (PAS), which is to be marketed and distributed by OOO Advance Trading. Rafarma aims to work with federal initiatives to fast track the modernization of Russia's pharmaceutical industry. It produces generic antibiotics, specialty pharmaceuticals, and its own line of proprietary products, which have been approved by the Russian Federation’s Ministry of Health. Working with Advanced Trading will allow Rafarma to increase production of PAS and to become one of the leading PAS suppliers throughout the Russian market. As one of Russia’s leading PAS distributors,…